The orphan drug market is projected to grow at a CAGR of 10.94% to reach US$285.799 billion in 2023 from US$153.275 billion in 2017. During the forecast period, prescription sales in the orphan drug sector are projected to grow at twice the rate of the overall prescription market. However, various government authorities encourage to develop and market orphan drugs. The cost incurred during the research and development of orphan drugs is higher when compared with non-orphan drugs. The orphan drug Read more...
The global regenerative drugs market is expected to grow at a CAGR of XX.XX% to reach a total market size of US$XX.XX billion by 2023, increasing from US$XX.XX billion in 2018.Regenerative drugs or medicines are used to heal body tissues or organs from within. The process is called rejuvenation in which these medicines repair the damaged body organs which otherwise cannot heal naturally. Regenerative medicines also help in replacement where healthy cells, tissues or organs are used from a dead o Read more...
The global Human Papilloma Virus (HPV) Vaccine market is expected to grow at a CAGR of 9.79% during the forecast period to reach a total market size of US$5.790 billion by 2024, increasing from US$3.305 billion in 2018.According to the WHO guidelines, routine vaccination is recommended to all countries along with other vaccinations. Human Papilloma Virus (HPV) Vaccine protects from certain types of Human Papilloma Viruses that can lead to cancer or genital warts. According to the WHO guidelines, Read more...
The global pet vaccine market is projected to witness a CAGR of 7.10% during the forecast period to reach a total market size of US$4.402 billion by 2023, increasing from US$3.124 billion in 2018. Regular Vaccination is an important part of a responsible pet ownership. Maintaining the pet’s immunity to diseases plays an important part in community health in general. The growing adoption rate of pets and growing community awareness regarding pet health has been significantly driving the Read more...
The global influenza vaccine market is projected to grow at a CAGR of 6.37% to reach US$7.547 billion by 2024, from US$5.209 billion in 2018. Due to the constant changing of circulating influenza viruses, influenza vaccines strains are changed annually (for both the Northern Hemisphere and the Southern Hemisphere) to more closely match currently circulating virus strains (source: WHO). Hence the rising R&D expenditure and advancements in vaccine technology are driving the growth of the globa Read more...
The precision medicine market is evaluated at US$60.422 billion for the year 2020 growing at a CAGR of 8.79% reaching the market size of US$100.168 billion by the year 2026. Increasing Chronic Diseases The market is expected to be driven by the growth and surge in several chronic diseases such as cardiovascular diseases, obesity, and other related diseases. According to the World Health Organization, Cardiovascular diseases are one of the major causes of deaths, globally, every Read more...
Europe over the counter (OTC) drug market is projected to grow at a CAGR of 4.19% during the forecast period to reach US$55.238 billion by 2026, from US$41.454 billion in 2019. Increasing health consciousness coupled with a surge in medical expenditure for better health is driving the market growth of the European OTC drug industry. Particularly, in Germany and France, a rise in health expenditure for longer and healthier life in supporting the market growth. Furthermore, the increasing pro Read more...
The Asia Pacific Over-the- Counter Drugs Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the Over-the- Counter Drugs market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, in additio Read more...
The Middle East and Africa Over-the- Counter Drugs Market was valued at US$X.XX billion in 2016 and is projected to expand at a CAGR of XX.XX% over the forecast period to reach US$X.XX billion by 2022. This research study examines the Over-the- Counter Drugs market on the basis of various segments. Major drivers, restraints, and opportunities have been mentioned to provide an exhaustive picture of the market. Furthermore, the current market trends related to the demand, supply, and sales, Read more...
The North America over-the-counter market was valued at US$43.341 billion in 2017 and is projected to expand at a CAGR of 4.24% over the forecast period to reach US$55.618 billion by 2023. Over the counter drugs are those drugs that are available to the consumers without the prescription. The high frequency of occurrences for many of the symptoms for which the over the counter medicines are required is driving the growth of the market. Moreover, the ability to provide convenience value alo Read more...
